Vascular biology 2026 - annual meeting of the north american vascular biology organization

Active Project Grant Awarded Last action

Award ID
R13HL184877
Recipient
Awarding agency
Obligated
$40,000

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 48% complete
Place of performance
Pacific Grove, CA 93950, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
The vascular biology field is undergoing a transformation, with new technological developments revealing the extent and mechanisms of vascular diversity. Vascular biologists have a growing appreciation for variation in vessel structure and function in different organs, across developmental stages, and in different disease contexts, leading to a deeper understanding of how these variations can impact therapeutic strategies for a wide range of pathologies. Two important factors that contribute to vascular diversity are (1) the genetic patterning of developing vessels, and (2) the surrounding environment in which vessels grow and remodel. Vascular biology 2026 (VB2026), organized by the north american vascular biology organization (navbo), will provide a forum for in-depth exploration of these factors by covering the themes of (1) vascular development and homeostasis, (2) vascular matrix biology and bioengineering, (3) inflammation, and (4) microcirculation. Regarding the latter theme, the microcirculatory society (MCS) will be a guest society at this meeting. MCS members bring classical expertise in microcirculatory physiology and function, complementing the molecular, genetic, and bioengineering expertise of navbo members, to mutual benefit. VB2026 will be an international meeting that draws researchers from academia, industry, hospitals and government, and incorporates both trainees and established scientists. The meeting will be held at the asilomar conference grounds, from october 18-22, 2026. The roster of organizers and invited speakers features researchers from various career levels and scientific backgrounds, providing broad perspectives for a meeting focused on vascular biology. Many speakers will be selected from abstract submissions, giving trainees and junior faculty additional opportunities to present their research that further promote career development. The meeting will include 14 concurrent sessions and five plenary sessions. The plenary sessions are mechanisms of vascular disease and resilience, the MCS president's symposium, a keynote lecture by DR. Kristy red-horse (stanford university), and navbo and MCS award lectures. These sessions will bring together all meeting participants in one room. Additional opportunities for formal and informal interactions will occur at poster sessions, group meals, including a reception on opening night. In SUM, VB2026 will foster exciting opportunities for vascular biologists at different training and career stages, scientific backgrounds, and perspectives to develop interdisciplinary collaborations that will synergistically enhance our understanding of vascular development, diversity, and therapeutic potential, thereby promoting the nhlbi's mission to prevent and treat cardiovascular disease.

Quick answers

Who received award R13HL184877?

R13HL184877 was awarded to North American Vascular Biology Organization, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on May 1, 2026.

How much is award R13HL184877 worth?

$40,000 has been obligated on R13HL184877.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login